SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-001477
Filing Date
2021-02-11
Accepted
2021-02-11 07:32:37
Documents
5
Period of Report
2021-02-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT a8kpressrele.htm 8-K 31595
2 ADDITIONAL EXHIBITS lumcuparpublicationpr_bla.htm EX-99 15009
3 IMAGE lumcuparpublicationpr_bla000.jpg GRAPHIC 4946
4 IMAGE lumcuparpublicationpr_bla001.jpg GRAPHIC 939
5 IMAGE lumcuparpublicationpr_bla002.jpg GRAPHIC 909
  Complete submission text file 0001654954-21-001477.txt   57560
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 21616724
SIC: 2834 Pharmaceutical Preparations